Buy Outlook Therapeutics Inc - Warrants - Series A (18/02/2022) Stock | OTLKW Stock Price & Latest News | Public
OTLKW

Outlook Therapeutics Inc - Warrants - Series A (18/02/2022)

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About OTLKW

    Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the identification, development, manufacture, and commercialization of complex biosimilar therapeutics. It focuses on monoclonal antibodies, in the disease areas of immunology ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Stats

    Market Cap
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High
    1 Year Low
    Open$0.17
    High$0.17
    Low$0.17

    Buy any stock with any amount of money.

    Download the App
    Download the app